Long-term result of maintenance treatment with tacrolimus ointment in chronic ocular graft-versus-host disease

Ji Won Jung, Young Ji Lee, Sang Chul Yoon, Tae-im Kim, Eungkweon Kim, KyoungYul Seo

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Purpose To investigate the efficacy and safety of long-term maintenance treatment with tacrolimus ointment in chronic ocular graft-vs-host disease (GVHD) with ocular surface inflammation. Design A retrospective interventional consecutive case series. Method Long-term maintenance treatment (≥6 months) with topical 0.02% tacrolimus ointment was applied to patients with chronic ocular GVHD with ocular surface inflammation (at least grade 2 inflammatory score). We evaluated the inflammatory score, steroid score and steroid use period of total duration, and numbers of inflammatory aggravations before and after tacrolimus treatment. The clinical outcomes were assessed by symptom score, ocular surface staining, Schirmer I test, tear break-up time (TBUT), and classification of chronic GVHD conjunctivitis at the initial and final examinations. Results Thirteen patients (24 eyes) were treated with tacrolimus ointment for up to 20 months (average 12.2 months). The ocular surface inflammatory score decreased from 2.8 to 0.6 (P =.001) within 2-8 weeks after starting tacrolimus ointment treatment. The numbers of inflammatory aggravation and the need for steroid treatment also decreased after initiating tacrolimus treatment. At the final follow-up, all patients reported improvement in clinical outcomes, compared to initial findings. Except for blurred vision or mild burning sensation, there were no reported side effects. Conclusion Considering the chronic course of GVHD, long-term maintenance treatment with tacrolimus ointment could be useful and safe to locally treat ocular surface inflammation in chronic ocular GVHD.

Original languageEnglish
Pages (from-to)519-527.e1
JournalAmerican Journal of Ophthalmology
Volume159
Issue number3
DOIs
Publication statusPublished - 2015 Mar 1

Fingerprint

Tacrolimus
Graft vs Host Disease
Ointments
Therapeutics
Steroids
Inflammation
Conjunctivitis
Tears
Staining and Labeling
Safety

All Science Journal Classification (ASJC) codes

  • Ophthalmology

Cite this

@article{e887dbeb986d42f69c95d67c717dfccf,
title = "Long-term result of maintenance treatment with tacrolimus ointment in chronic ocular graft-versus-host disease",
abstract = "Purpose To investigate the efficacy and safety of long-term maintenance treatment with tacrolimus ointment in chronic ocular graft-vs-host disease (GVHD) with ocular surface inflammation. Design A retrospective interventional consecutive case series. Method Long-term maintenance treatment (≥6 months) with topical 0.02{\%} tacrolimus ointment was applied to patients with chronic ocular GVHD with ocular surface inflammation (at least grade 2 inflammatory score). We evaluated the inflammatory score, steroid score and steroid use period of total duration, and numbers of inflammatory aggravations before and after tacrolimus treatment. The clinical outcomes were assessed by symptom score, ocular surface staining, Schirmer I test, tear break-up time (TBUT), and classification of chronic GVHD conjunctivitis at the initial and final examinations. Results Thirteen patients (24 eyes) were treated with tacrolimus ointment for up to 20 months (average 12.2 months). The ocular surface inflammatory score decreased from 2.8 to 0.6 (P =.001) within 2-8 weeks after starting tacrolimus ointment treatment. The numbers of inflammatory aggravation and the need for steroid treatment also decreased after initiating tacrolimus treatment. At the final follow-up, all patients reported improvement in clinical outcomes, compared to initial findings. Except for blurred vision or mild burning sensation, there were no reported side effects. Conclusion Considering the chronic course of GVHD, long-term maintenance treatment with tacrolimus ointment could be useful and safe to locally treat ocular surface inflammation in chronic ocular GVHD.",
author = "Jung, {Ji Won} and Lee, {Young Ji} and Yoon, {Sang Chul} and Tae-im Kim and Eungkweon Kim and KyoungYul Seo",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.ajo.2014.11.035",
language = "English",
volume = "159",
pages = "519--527.e1",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "3",

}

Long-term result of maintenance treatment with tacrolimus ointment in chronic ocular graft-versus-host disease. / Jung, Ji Won; Lee, Young Ji; Yoon, Sang Chul; Kim, Tae-im; Kim, Eungkweon; Seo, KyoungYul.

In: American Journal of Ophthalmology, Vol. 159, No. 3, 01.03.2015, p. 519-527.e1.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Long-term result of maintenance treatment with tacrolimus ointment in chronic ocular graft-versus-host disease

AU - Jung, Ji Won

AU - Lee, Young Ji

AU - Yoon, Sang Chul

AU - Kim, Tae-im

AU - Kim, Eungkweon

AU - Seo, KyoungYul

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Purpose To investigate the efficacy and safety of long-term maintenance treatment with tacrolimus ointment in chronic ocular graft-vs-host disease (GVHD) with ocular surface inflammation. Design A retrospective interventional consecutive case series. Method Long-term maintenance treatment (≥6 months) with topical 0.02% tacrolimus ointment was applied to patients with chronic ocular GVHD with ocular surface inflammation (at least grade 2 inflammatory score). We evaluated the inflammatory score, steroid score and steroid use period of total duration, and numbers of inflammatory aggravations before and after tacrolimus treatment. The clinical outcomes were assessed by symptom score, ocular surface staining, Schirmer I test, tear break-up time (TBUT), and classification of chronic GVHD conjunctivitis at the initial and final examinations. Results Thirteen patients (24 eyes) were treated with tacrolimus ointment for up to 20 months (average 12.2 months). The ocular surface inflammatory score decreased from 2.8 to 0.6 (P =.001) within 2-8 weeks after starting tacrolimus ointment treatment. The numbers of inflammatory aggravation and the need for steroid treatment also decreased after initiating tacrolimus treatment. At the final follow-up, all patients reported improvement in clinical outcomes, compared to initial findings. Except for blurred vision or mild burning sensation, there were no reported side effects. Conclusion Considering the chronic course of GVHD, long-term maintenance treatment with tacrolimus ointment could be useful and safe to locally treat ocular surface inflammation in chronic ocular GVHD.

AB - Purpose To investigate the efficacy and safety of long-term maintenance treatment with tacrolimus ointment in chronic ocular graft-vs-host disease (GVHD) with ocular surface inflammation. Design A retrospective interventional consecutive case series. Method Long-term maintenance treatment (≥6 months) with topical 0.02% tacrolimus ointment was applied to patients with chronic ocular GVHD with ocular surface inflammation (at least grade 2 inflammatory score). We evaluated the inflammatory score, steroid score and steroid use period of total duration, and numbers of inflammatory aggravations before and after tacrolimus treatment. The clinical outcomes were assessed by symptom score, ocular surface staining, Schirmer I test, tear break-up time (TBUT), and classification of chronic GVHD conjunctivitis at the initial and final examinations. Results Thirteen patients (24 eyes) were treated with tacrolimus ointment for up to 20 months (average 12.2 months). The ocular surface inflammatory score decreased from 2.8 to 0.6 (P =.001) within 2-8 weeks after starting tacrolimus ointment treatment. The numbers of inflammatory aggravation and the need for steroid treatment also decreased after initiating tacrolimus treatment. At the final follow-up, all patients reported improvement in clinical outcomes, compared to initial findings. Except for blurred vision or mild burning sensation, there were no reported side effects. Conclusion Considering the chronic course of GVHD, long-term maintenance treatment with tacrolimus ointment could be useful and safe to locally treat ocular surface inflammation in chronic ocular GVHD.

UR - http://www.scopus.com/inward/record.url?scp=84922654120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922654120&partnerID=8YFLogxK

U2 - 10.1016/j.ajo.2014.11.035

DO - 10.1016/j.ajo.2014.11.035

M3 - Article

C2 - 25498356

AN - SCOPUS:84922654120

VL - 159

SP - 519-527.e1

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 3

ER -